Advertisement
Screener

SOLIGENIX, INC. (SNGX) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

SOLIGENIX, INC. Research and Development Expense

SOLIGENIX, INC. (SNGX) reported Research and Development Expense of $974.09 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07

  • SOLIGENIX, INC. research and development expense for the quarter ending 2026-06-30 was $974.09K, a 41.92% decline year-over-year.
  • SOLIGENIX, INC. research and development expense for the quarter ending 2026-03-31 was $1.78M, a 8.21% decline year-over-year.
  • SOLIGENIX, INC. research and development expense for the quarter ending 2025-12-31 was $2.28M, a 14.12% decline year-over-year.
  • SOLIGENIX, INC. research and development expense for the quarter ending 2025-09-30 was $1.58M, a 63.51% increase year-over-year.
  • SOLIGENIX, INC. research and development expense for fiscal 2025 was $7.49M, a 43.31% increase from fiscal 2024.
  • SOLIGENIX, INC. research and development expense for fiscal 2024 was $5.22M, a 57.68% increase from fiscal 2023.
  • SOLIGENIX, INC. research and development expense for fiscal 2023 was $3.31M, a 58.30% decline from fiscal 2022.
  • SOLIGENIX, INC. research and development expense for fiscal 2022 was $7.94M, a 2.95% decline from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2026-06-30$974.09K
10-Q · filed 2026-08-07
$2.76M
10-Q · filed 2026-08-07
$5.04M
derived: sum of 3 quarters · filed 2026-08-07
$6.62M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$1.78M
10-Q · filed 2026-05-08
$4.07M
derived: sum of 2 quarters · filed 2026-05-08
$5.65M
derived: sum of 3 quarters · filed 2026-05-08
$7.33M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$2.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$3.87M
derived: sum of 2 quarters · filed 2026-03-31
$5.54M
derived: sum of 3 quarters · filed 2026-08-07
$7.49M
10-K · filed 2026-03-31
2025-09-30$1.58M
10-Q · filed 2025-11-07
$3.26M
derived: sum of 2 quarters · filed 2026-08-07
$5.20M
10-Q · filed 2025-11-07
$7.86M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$1.68M
10-Q · filed 2026-08-07
$3.62M
10-Q · filed 2026-08-07
$6.28M
derived: sum of 3 quarters · filed 2026-08-07
$7.25M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$1.94M
10-Q · filed 2026-05-08
$2.23M
10-Q · filed 2025-05-09
$4.60M
derived: sum of 2 quarters · filed 2026-05-08
$5.57M
derived: sum of 3 quarters · filed 2026-05-08
$6.07M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$2.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$3.63M
derived: sum of 2 quarters · filed 2026-03-31
$4.13M
derived: sum of 3 quarters · filed 2026-03-31
$5.22M
10-K · filed 2026-03-31
2024-09-30$968.69K
10-Q · filed 2025-11-07
$1.47M
derived: sum of 2 quarters · filed 2025-11-07
$2.56M
10-Q · filed 2025-11-07
$3.34M
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30$501.16K
10-Q · filed 2025-08-14
$1.60M
10-Q · filed 2025-08-14
$2.37M
derived: sum of 3 quarters · filed 2025-08-14
$3.20M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$1.10M
10-Q · filed 2025-05-09
$1.87M
derived: sum of 2 quarters · filed 2025-05-09
$2.70M
derived: sum of 3 quarters · filed 2025-05-09
$3.46M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$777.53K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
$1.60M
derived: sum of 2 quarters · filed 2025-03-21
$2.37M
derived: sum of 3 quarters · filed 2025-03-21
$3.31M
10-K · filed 2025-03-21
2023-09-30$826.01K
10-Q · filed 2024-11-08
$1.59M
derived: sum of 2 quarters · filed 2024-11-08
$2.54M
10-Q · filed 2024-11-08
$4.89M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$762.70K
10-Q · filed 2024-08-09
$1.71M
10-Q · filed 2024-08-09
$4.07M
derived: sum of 3 quarters · filed 2024-08-09
$5.86M
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$946.45K
10-Q · filed 2024-05-10
$3.30M
derived: sum of 2 quarters · filed 2024-05-10
$5.10M
derived: sum of 3 quarters · filed 2024-05-10
$7.14M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$2.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15
$4.15M
derived: sum of 2 quarters · filed 2024-03-15
$6.20M
derived: sum of 3 quarters · filed 2024-03-15
$7.94M
10-K · filed 2024-03-15
2022-09-30$1.79M
10-Q · filed 2023-11-13
$3.84M
derived: sum of 2 quarters · filed 2023-11-13
$5.59M
10-Q · filed 2023-11-13
$8.29M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$2.05M
10-Q · filed 2023-08-21
$3.79M
10-Q · filed 2023-08-21
$6.50M
derived: sum of 3 quarters · filed 2023-08-21
$8.73M
derived: sum of 4 quarters · filed 2023-08-21
2022-03-31$1.75M
10-Q · filed 2023-05-15
$4.45M
derived: sum of 2 quarters · filed 2023-05-15
$6.69M
derived: sum of 3 quarters · filed 2023-05-15
$8.62M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$2.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$4.94M
derived: sum of 2 quarters · filed 2023-03-31
$6.88M
derived: sum of 3 quarters · filed 2023-03-31
$8.19M
10-K · filed 2023-03-31
$8.39M
10-K · filed 2022-03-29
2021-09-30$2.24M
10-Q · filed 2022-11-10
$2.48M
10-Q · filed 2021-11-12
$4.17M
derived: sum of 2 quarters · filed 2022-11-10
$5.48M
10-Q · filed 2022-11-10
$5.95M
10-Q · filed 2021-11-12
$9.14M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$1.94M
10-Q · filed 2022-08-12
$2.10M
10-Q · filed 2021-08-13
$3.25M
10-Q · filed 2022-08-12
$3.47M
10-Q · filed 2021-08-13
$6.91M
derived: sum of 3 quarters · filed 2022-08-12
$8.17M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$1.31M
10-Q · filed 2022-05-13
$1.37M
10-Q · filed 2021-05-18
$4.97M
derived: sum of 2 quarters · filed 2022-05-13
$6.24M
derived: sum of 3 quarters · filed 2022-05-13
$8.41M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$3.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$4.93M
derived: sum of 2 quarters · filed 2022-03-29
$7.10M
derived: sum of 3 quarters · filed 2022-03-29
$9.80M
10-K · filed 2022-03-29
$10.15M
10-K · filed 2021-03-30
2020-09-30$1.27M
10-Q · filed 2021-11-12
$3.44M
derived: sum of 2 quarters · filed 2021-11-12
$6.14M
10-Q · filed 2021-11-12
$8.50M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$2.17M
10-Q · filed 2021-08-13
$4.87M
10-Q · filed 2021-08-13
$7.23M
derived: sum of 3 quarters · filed 2021-08-13
$9.50M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31$2.70M
10-Q · filed 2021-05-18
$5.06M
derived: sum of 2 quarters · filed 2021-05-18
$7.33M
derived: sum of 3 quarters · filed 2021-05-18
$9.18M
derived: sum of 4 quarters · filed 2021-05-18
2019-12-31$2.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
$4.63M
derived: sum of 2 quarters · filed 2021-03-30
$6.48M
derived: sum of 3 quarters · filed 2021-03-30
$8.12M
10-K · filed 2021-03-30
2019-09-30$2.27M
10-Q · filed 2020-11-12
$4.12M
derived: sum of 2 quarters · filed 2020-11-12
$5.76M
10-Q · filed 2020-11-12
$8.14M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$1.85M
10-Q · filed 2020-08-14
$3.50M
10-Q · filed 2020-08-14
$5.87M
derived: sum of 3 quarters · filed 2020-08-14
$7.27M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$1.64M
10-Q · filed 2020-05-15
$4.02M
derived: sum of 2 quarters · filed 2020-05-15
$5.41M
derived: sum of 3 quarters · filed 2020-05-15
$6.58M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$2.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$3.77M
derived: sum of 2 quarters · filed 2020-03-30
$4.94M
derived: sum of 3 quarters · filed 2020-03-30
$6.75M
10-K · filed 2020-03-30
2018-09-30$1.39M
10-Q · filed 2019-11-12
$2.57M
derived: sum of 2 quarters · filed 2019-11-12
$4.38M
10-Q · filed 2019-11-12
$6.27M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$1.17M
10-Q · filed 2019-08-13
$2.97M
10-Q · filed 2019-08-13
$4.87M
derived: sum of 3 quarters · filed 2019-08-13
$5.48M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31$1.80M
10-Q · filed 2019-05-14
$3.70M
derived: sum of 2 quarters · filed 2019-05-14
$4.31M
derived: sum of 3 quarters · filed 2019-05-14
$6.09M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$1.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
$2.51M
derived: sum of 2 quarters · filed 2019-03-26
$4.29M
derived: sum of 3 quarters · filed 2019-03-26
$5.51M
10-K · filed 2019-03-26
2017-09-30$605.72K
10-Q · filed 2018-11-09
$2.39M
derived: sum of 2 quarters · filed 2018-11-09
$3.61M
10-Q · filed 2018-11-09
$4.47M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30$1.78M
10-Q · filed 2018-08-08
$3.00M
10-Q · filed 2018-08-08
$3.86M
derived: sum of 3 quarters · filed 2018-08-08
$5.04M
derived: sum of 4 quarters · filed 2018-08-08
2017-03-31$1.22M
10-Q · filed 2018-05-11
$2.08M
derived: sum of 2 quarters · filed 2018-05-11
$3.26M
derived: sum of 3 quarters · filed 2018-05-11
$4.08M
derived: sum of 4 quarters · filed 2018-05-11
2016-12-31$862.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$2.04M
derived: sum of 2 quarters · filed 2018-03-15
$2.87M
derived: sum of 3 quarters · filed 2018-03-15
$4.30M
10-K · filed 2018-03-15
2016-09-30$1.18M
10-Q · filed 2017-11-06
$2.01M
derived: sum of 2 quarters · filed 2017-11-06
$3.43M
10-Q · filed 2017-11-06
$5.10M
derived: sum of 4 quarters · filed 2017-11-06
2016-06-30$827.83K
10-Q · filed 2017-08-11
$2.26M
10-Q · filed 2017-08-11
$3.92M
derived: sum of 3 quarters · filed 2017-08-11
$5.18M
derived: sum of 4 quarters · filed 2017-08-11
2016-03-31$1.43M
10-Q · filed 2017-05-11
$3.10M
derived: sum of 2 quarters · filed 2017-05-11
$4.36M
derived: sum of 3 quarters · filed 2017-05-11
$5.80M
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31$1.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27
$2.93M
derived: sum of 2 quarters · filed 2017-03-27
$4.37M
derived: sum of 3 quarters · filed 2017-03-27
$5.40M
10-K · filed 2017-03-27
2015-09-30$1.26M
10-Q · filed 2016-11-10
$2.70M
derived: sum of 2 quarters · filed 2016-11-10
$3.73M
10-Q · filed 2016-11-10
$1.49M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$1.44M
10-Q · filed 2016-08-11
$2.47M
10-Q · filed 2016-08-11
$226.31K
derived: sum of 3 quarters · filed 2016-08-11
$5.32M
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31$1.03M
10-Q · filed 2016-05-12
-$1.22M
derived: sum of 2 quarters · filed 2016-05-12
$3.87M
derived: sum of 3 quarters · filed 2016-05-12
$5.09M
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31-$2.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24
$2.84M
derived: sum of 2 quarters · filed 2016-03-24
$4.06M
derived: sum of 3 quarters · filed 2016-03-24
$5.09M
10-K · filed 2016-03-24
2014-09-30$5.09M
10-Q · filed 2015-11-12
$6.30M
derived: sum of 2 quarters · filed 2015-11-12
$7.33M
10-Q · filed 2015-11-12
$8.29M
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30$1.21M
10-Q · filed 2015-08-12
$2.24M
10-Q · filed 2015-08-12
$3.20M
derived: sum of 3 quarters · filed 2015-08-12
$4.42M
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$1.03M
10-Q · filed 2015-05-14
$1.99M
derived: sum of 2 quarters · filed 2015-05-14
$3.20M
derived: sum of 3 quarters · filed 2015-05-14
$5.35M
derived: sum of 4 quarters · filed 2015-05-14
2013-12-31$957.49K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25
$2.17M
derived: sum of 2 quarters · filed 2015-03-25
$4.31M
derived: sum of 3 quarters · filed 2015-03-25
$5.07M
10-K · filed 2015-03-25
2013-09-30$1.22M
10-Q · filed 2014-11-10
$3.36M
derived: sum of 2 quarters · filed 2014-11-10
$4.11M
10-Q · filed 2014-11-10
$4.97M
derived: sum of 4 quarters · filed 2014-11-10
2013-06-30$2.14M
10-Q · filed 2014-08-11
$2.90M
10-Q · filed 2014-08-11
$3.76M
derived: sum of 3 quarters · filed 2014-08-11
$4.13M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$756.65K
10-Q · filed 2014-05-12
$1.62M
derived: sum of 2 quarters · filed 2014-05-12
$1.99M
derived: sum of 3 quarters · filed 2014-05-12
$2.49M
derived: sum of 4 quarters · filed 2014-05-12
2012-12-31$860.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26
$1.23M
derived: sum of 2 quarters · filed 2014-03-26
$1.73M
derived: sum of 3 quarters · filed 2014-03-26
$2.61M
10-K · filed 2014-03-26
2012-09-30$371.34K
10-Q · filed 2013-11-12
$872.32K
derived: sum of 2 quarters · filed 2013-11-12
$1.75M
10-Q · filed 2013-11-12
$2.79M
derived: sum of 4 quarters · filed 2013-11-12
2012-06-30$500.98K
10-Q · filed 2013-08-12
$1.38M
10-Q · filed 2013-08-12
$2.42M
derived: sum of 3 quarters · filed 2013-08-12
$4.76M
derived: sum of 4 quarters · filed 2013-08-12
2012-03-31$876.79K
10-Q · filed 2013-05-03
$1.92M
derived: sum of 2 quarters · filed 2013-05-03
$4.26M
derived: sum of 3 quarters · filed 2013-05-03
$5.78M
derived: sum of 4 quarters · filed 2013-05-03
2011-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$3.39M
derived: sum of 2 quarters · filed 2013-02-26
$4.90M
derived: sum of 3 quarters · filed 2013-02-26
$6.27M
10-K · filed 2013-02-26
2011-09-30$2.34M
10-Q · filed 2012-11-14
$3.86M
derived: sum of 2 quarters · filed 2012-11-14
$5.23M
10-Q · filed 2012-11-14
$7.19M
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$1.51M
10-Q · filed 2012-08-10
$1.31M
10-Q · filed 2011-08-12
$2.89M
10-Q · filed 2012-08-10
$2.56M
10-Q · filed 2011-08-12
$4.85M
derived: sum of 3 quarters · filed 2012-08-10
$6.12M
derived: sum of 4 quarters · filed 2012-08-10
2011-03-31$1.37M
10-Q · filed 2012-05-14
$3.33M
derived: sum of 2 quarters · filed 2012-05-14
$4.61M
derived: sum of 3 quarters · filed 2012-05-14
$5.68M
derived: sum of 4 quarters · filed 2012-05-14
2010-12-31$1.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27
$3.24M
derived: sum of 2 quarters · filed 2012-03-27
$4.31M
derived: sum of 3 quarters · filed 2012-03-27
$5.99M
10-K · filed 2012-03-27
2010-09-30$1.28M
10-Q · filed 2011-11-14
$2.35M
derived: sum of 2 quarters · filed 2011-11-14
$4.03M
10-Q · filed 2011-11-14
2010-06-30$1.07M
10-Q · filed 2011-08-12
$2.67M
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Imunon, Inc. (IMNN)United States$0.008B-0.56
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97